Initially, we analyzed mRNA expression in endometriosis lesions and found that shEZH2 treatment (EMP/GSK343) increased ERα mRNA while decreasing TNFα mRNA, with no effect on ERβ compared to EMP/VEH group. The gene discussed is ESR2; the disease is endometriosis.